Advertisement
Advertisement

DYN

DYN logo

Dyne Therapeutics, Inc. Common Stock

19.33
USD
Sponsored
+0.77
+4.15%
May 29, 16:00 UTC -4
Closed
exchange

After-Market

19.33

0.00
0.00%

Dyne Therapeutics, Inc. Common Stock Profile

About

Dyne Therapeutics Inc. is a muscle disease company focused on advancing innovative life-transforming therapeutics for patients with genetically driven diseases. The company's proprietary platform includes FORCE(TM). Dyne Therapeutics Inc. is based in WALTHAM, Mass.

Info & Links

CEO

John G. Cox

Headquarters

1560 TRAPELO ROAD
WALTHAM, MA 02451, UNITED STATES

Industry

Medical Drugs

Sector

Medical

Website

www.dyne-tx.com

Auditor

Deloitte & Touche LLP

Share holders

10

Employees

258

Dyne Therapeutics, Inc. Common Stock Statistics

Valuation Measures

Market Capitalization2

3.20B

Enterprise Value

2.60B

Enterprise Value/EBITDA(ttm)

-5.52

Price to Earnings Ratio(ttm)

--

Price to Sales(ttm)

--

Price to Book(mrq)

2.84

Price to Cash(ytd)

--

Profitability

Gross Margin(ttm)

0.00%

Operating Margin(ttm)

--

Profit Margin(ttm)

0.00%

Return on Equity(ttm)

-61.46%

Return on Invested Capital(ttm)

-57.43%

Return on Assets(ttm)

-50.94%

Income Statement

Revenue(ttm)

0.00

Revenue Per Share(ttm)

0.00

Gross Profit(ttm)

0.00

EBITDA(ttm)3

-470.48M

Net Income Available to Common(ttm)

-451.71M

Diluted EPS(ttm)

-3.54

Share Statistics

Beta (5Y Monthly)

1.29

52-Week Change

57.92%

S&P 500 52-Week Change

28.22%

S&P 500 Member

Yes

Stock Optionable

Yes

Total Shares Outstanding1

165.31M

Dividend Yield

0.00%

Float4

141.69M

% Held by Insiders

14.14%

% Held by Institutions

96.68%

Balance Sheet

Total Cash(mrq)

972.16M

Total Cash Per Share(mrq)

5.88

Total Debt(mrq)

155.60M

Total Debt/Equity(mrq)

15.32%

Current Ratio(mrq)

22.25%

Quick Ratio(mrq)

22.25%

Book Value Per Share(mrq)

5.89

Cash Flow

Operating Cash Flow Per Share(ytd)

-3.14

Free Cash Flow(ytd)

-405.13M

Table Key

mrq = Most Recent Quarter

ttm = Trailing Twelve Months

ytd = Year To Date

Footnotes

Data provided by Zacks Investment Research or calculated by FXEmpire. All numbers are rounded to the closest decimal.

  • 1 Total Shares outstanding is taken from the most recently filed quarterly or annual report.
  • 2 Market Cap is calculated using total shares outstanding and the most recent share price.
  • 3 EBITDA is calculated using methodology that may differ from that used by a company in its reporting.
  • 4 The float is a measure of the number of shares available for trading by the public. It's calculated by taking the number of issued and outstanding shares minus any restricted stock, which might not be publicly traded.
Advertisement